59 Life Sciences Companies
That Have Made a strategic executive hire
Track life sciences companies that recently hired key executives or leaders in real-time.
Download this list
59 companies, each with its dated signal
Get 9 rows free · Key Hire Life Sciences Companies
The list's first rows in Excel, with every column the full file has and how full each one is. One e-mail, then at most two short notes.
Need it kept current? See how Signal Tracker works
Other Signals in Life Sciences:
This page lists 59 life sciences companies that have made a strategic executive hire recently. Each company detected a key hire signal through Bounce Watch's real-time monitoring system that tracks 40+ growth and risk indicators across thousands of companies.
Arbor Biotechnologies
Cambridge, United States (2016)
Genetic medicines for genetic diseases
Apoha
London, United Kingdom (2021)
Teaching machines to see, feel, taste, smell, and understand matter.
NOETIK
South San Francisco, United States (2022)
Noetik is an AI-native biotech harnessing self-supervised learning to discover better precision immunothe...
Engitix Therapeutics
London, United Kingdom (2016)
Decoding the ECM space to unlock unprecedented therapies for chronic diseases
ImmunoScape
Singapore (2016)
Transforming Cancer Therapy with Our Novel Seed-and-Boost Approach
Nuclera
Cambridge, United Kingdom (2013)
Bring rapid protein access to your benchtop with eProtein Discovery
Pharvaris
Zug, Switzerland (2015)
Pioneering science for patient choice
HMNC Brain Health
Germany (2010)
Transforming Therapy of Depression and Anxiety 🧬
Scenic Biotech
The Netherlands (2017)
Evolution-inspired medicine
Track Key Hire Signals in Real-Time
Get instant alerts when life sciences companies show key hire activity. Monitor 40+ signal types across your target market.
Book a demo
Aiforia Technologies
Finland (2013)
Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.
FluoSphera
Geneva, Switzerland (2021)
The only company with a suite of systemic and high-throughput in vitro drug discovery solutions
Benchling
San Francisco, United States (2012)
On a mission to unlock the power of biotechnology and empower our global customers to get to milestones &...
IMU Biosciences
London, United Kingdom (2019)
Decoding the immune system to transform how we understand, diagnose and treat disease. We call this HD Im...
Automata
London, United Kingdom (2015)
Where legacy ends, Automata begins.
VoxCell
Canada (2020)
Redefining drug development. Replicating human tissues.
A-Alpha Bio
Seattle, United States (2017)
The protein-protein interaction company
Terray Therapeutics
Pasadena, United States (2018)
Everything small molecule drug discovery should be.
Ignota Labs
Cambridge, United Kingdom (2021)
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to...
Quanterix
Billerica, United States (2007)
Powering Biomarkers from Discovery to Diagnostics
Tacalyx GmbH
Berlin, Germany (2019)
Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need
Strand Therapeutics
Boston, United States (2017)
Where synthetic biology meets RNA therapeutics
Arctoris
United Kingdom (2016)
Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford, UK.
Immunic Therapeutics
United States (2016)
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoi...
Invenra
Madison, United States (2011)
Invenra operates as a biotechnology company focused on early stage drug discovery
Atrandi Biosciences
Lithuania (2016)
Semi-Permeable Capsules (SPCs) for single-cell analysis and multiomics at scale
Ultima Genomics
Fremont, United States (2016)
Unleashing the power of genomics at scale
Infinimmune
Alameda, United States (2022)
Treating human disease with truly human therapeutics.
Bicara Therapeutics
Boston, United States (2020)
Pioneering bifunctional antibodies for targeted tumor modulation
Pentixapharm AG
Berlin, Germany (2019)
improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy
Aspect Biosystems
Canada (2013)
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Epitopea
Montreal, Canada (2021)
Exploiting a new class of tumour specific antigens for cancer therapy
NewAmsterdam Pharma Corporation
Aventura, United States (2019)
NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabo...
Checkerspot
Alameda, United States (2016)
Designing fats and oils through precision fermentation.
DR. KADE Health Care
Berlin, Germany (1886)
WIR MACHEN LEBENSQUALITÄT
Prime Medicine, Inc.
Cambridge, United States (2019)
Delivering on the promise of Prime Editing
Rapport Therapeutics
United States (2022)
Precision medicines to match the complexity of the human brain.
ALX Oncology
South San Francisco, United States (2015)
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boosting the immune...
The Protein Brewery
The Netherlands (2020)
Future-Proof Nutrition
MGI
Shenzhen, China (2016)
Leading Life Science Innovation
Ansa Biotechnologies, Inc.
Emeryville, United States (2018)
High-fidelity DNA synthesis using enzymes
Ability Biotherapeutics
Montreal, Canada (2023)
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoi...
Voyager Therapeutics, Inc.
Lexington, United States (2014)
Leveraging genetics to treat neurological diseases
Sudo Biosciences
Carmel, United States (2020)
Developing precision TYK2 therapeutics.
Absci
Vancouver, United States (2011)
Unlocking differentiated biology with generative AI
Promega Corporation
Madison, United States (1978)
Sana Biotechnology, Inc.
Seattle, United States (2018)
Focused on creating and delivering engineered cells as medicines for patients
Tubulis GmbH
Germany (2019)
Reimagining ADCs.
Integrated Biosciences, Inc.
Redwood City, United States (2022)
Unravelling complex biology with optogenetics, chemistry and computation for small molecule discovery.
BDD
United Kingdom (1999)
Redefining Early Stage Development
BioNTech SE
Mainz, Germany (2008)
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infec...
Flare Therapeutics
Cambridge, United States (2021)
Trailblazing the path to drugging transcription factors to discover precision medicines for cancer & othe...
Formo
Berlin, Germany (2019)
Biotech engine for food and nutrition - starting with Enhanced Casein
HepaRegeniX GmbH
Tubingen, Germany (2017)
Unlocking liver regeneration - delivering recovery
Volastra Therapeutics
New York, United States (2019)
Clinical stage biotech developing a powerful new class of cancer therapies exploiting chromosomal instabi...
Truvian
San Diego, United States (2015)
blood testing anyone. anywhere.
CHARM Therapeutics
London, United Kingdom (2021)
Protein-ligand intelligence to deliver next generation small molecule therapeutics
Myricx Bio
London, United Kingdom (2019)
Developing a new class of ADCs based on NMT inhibition to treat cancer
Affinia Therapeutics
Waltham, United States (2019)
Building the next generation of gene therapies
Anavo Therapeutics BV
The Netherlands (2020)
UNLOCKING THE PHOSPHATASE TARGET CLASS
What changed at these Life Sciences companies recently?
We recorded 216 changes here in the last 180 days, including 70 product launches, 43 awards, 39 hiring moves, 19 milestones and 14 traction updates. Each entry below carries the date we observed it, from public sources.
-
Benchling
— New Product Launched
-
Formo
— Award Received
-
The Protein Brewery
— Expansion Announced
-
Aiforia Technologies
— New Feature Launched
-
Absci
— Regulatory Approval
-
Automata
— New Feature Launched
-
NOETIK
— Award Received
-
Ansa Biotechnologies, Inc.
— New Product Launched